UniDoc Announces LIFE Offering
UniDoc Health Corp (CSE:UDOC) has announced a non-brokered private placement LIFE offering to raise up to $500,000 through the issuance of up to 2,000,000 units at $0.25 per unit. Each unit comprises one common share and one-half of a transferrable warrant, with each full warrant allowing the purchase of an additional common share at $0.35 for 24 months after closing.
The proceeds will support inventory, marketing and investor relations services, working capital, and general corporate purposes. The offering, expected to close around April 11, 2025, will be conducted under the listed issuer financing exemption in British Columbia, with securities issued to Canadian residents having no resale restrictions.
UniDoc Health Corp (CSE:UDOC) ha annunciato un'offerta di collocamento privato non intermediato LIFE per raccogliere fino a $500,000 attraverso l'emissione di fino a 2,000,000 unità a $0.25 per unità. Ogni unità comprende una azione ordinaria e una metà di un warrant trasferibile, con ogni warrant intero che consente l'acquisto di un'ulteriore azione ordinaria a $0.35 per 24 mesi dopo la chiusura.
I proventi supporteranno l'inventario, i servizi di marketing e relazioni con gli investitori, il capitale circolante e scopi aziendali generali. L'offerta, prevista per chiudere intorno al 11 aprile 2025, sarà condotta sotto l'esenzione di finanziamento per emittenti quotati nella Columbia Britannica, con titoli emessi a residenti canadesi senza restrizioni alla rivendita.
UniDoc Health Corp (CSE:UDOC) ha anunciado una oferta de colocación privada no mediada LIFE para recaudar hasta $500,000 a través de la emisión de hasta 2,000,000 de unidades a $0.25 por unidad. Cada unidad comprende una acción ordinaria y la mitad de un warrant transferible, con cada warrant completo permitiendo la compra de una acción ordinaria adicional a $0.35 durante 24 meses después del cierre.
Los ingresos apoyarán el inventario, los servicios de marketing y relaciones con inversores, el capital de trabajo y fines corporativos generales. Se espera que la oferta se cierre alrededor del 11 de abril de 2025, y se llevará a cabo bajo la exención de financiamiento para emisores listados en Columbia Británica, con valores emitidos a residentes canadienses sin restricciones de reventa.
UniDoc Health Corp (CSE:UDOC)는 최대 $500,000를 모금하기 위해 비중개 개인 배치 LIFE 제안을 발표했습니다. 이는 $0.25당 1단위로 최대 2,000,000 단위를 발행하는 것입니다. 각 단위는 하나의 보통주와 이전 가능한 워런트의 절반으로 구성되며, 각 전체 워런트는 종료 후 24개월 동안 $0.35에 추가 보통주를 구매할 수 있게 합니다.
수익금은 재고, 마케팅 및 투자자 관계 서비스, 운영 자본 및 일반 기업 목적을 지원합니다. 이 제안은 2025년 4월 11일 경에 마감될 예정이며, 브리티시컬럼비아의 상장 발행자 금융 면세 혜택에 따라 진행되며, 캐나다 거주자에게 발행된 증권은 재판매 제한이 없습니다.
UniDoc Health Corp (CSE:UDOC) a annoncé une offre de placement privé non intermédié LIFE pour lever jusqu'à $500,000 par l'émission de jusqu'à 2,000,000 d'unités à $0.25 par unité. Chaque unité comprend une action ordinaire et une demi-option de transfert, chaque option complète permettant l'achat d'une action ordinaire supplémentaire à $0.35 pendant 24 mois après la clôture.
Les produits soutiendront l'inventaire, les services de marketing et de relations avec les investisseurs, le fonds de roulement et les objectifs d'entreprise généraux. L'offre, qui devrait se clôturer autour du 11 avril 2025, sera réalisée dans le cadre de l'exemption de financement des émetteurs cotés en Colombie-Britannique, avec des titres émis à des résidents canadiens n'ayant aucune restriction de revente.
UniDoc Health Corp (CSE:UDOC) hat eine nicht vermittelte Privatplatzierung LIFE angekündigt, um bis zu $500,000 durch die Ausgabe von bis zu 2,000,000 Einheiten zu einem Preis von $0.25 pro Einheit zu beschaffen. Jede Einheit besteht aus einer Stammaktie und einer halben übertragbaren Optionsschein, wobei jeder volle Optionsschein den Kauf einer zusätzlichen Stammaktie zu $0.35 für 24 Monate nach Abschluss ermöglicht.
Die Erlöse werden zur Unterstützung von Inventar, Marketing- und Investor Relations-Dienstleistungen, Betriebskapital und allgemeinen Unternehmenszwecken verwendet. Die Platzierung, die voraussichtlich um den 11. April 2025 abgeschlossen wird, wird unter der Ausnahmeregelung für börsennotierte Emittenten in British Columbia durchgeführt, wobei an kanadische Bewohner ausgegebene Wertpapiere keine Verkaufsbeschränkungen haben.
- No resale restrictions for Canadian investors, improving liquidity potential
- Warrant structure provides additional upside potential at $0.35 per share
- Dilutive impact on existing shareholders through issuance of up to 2,000,000 new units
- Offering price of $0.25 per unit may represent a discount to market price
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
VANCOUVER, BC / ACCESS Newswire / April 4, 2025 / UniDoc Health Corp. (CSE:UDOC) ("UniDoc" or the "Company") is pleased to announce a non-brokered private placement LIFE offering (the "Offering") for total gross proceeds of up to
Each Unit will consist of one common share in the capital of the Company and one-half of one transferrable common share purchase warrant (a "Warrant"). Each Warrant will entitle the holder to acquire an additional common share at a price of
The Company plans to use the proceeds from the Offering for inventory, marketing and investor relations services, working capital, and general corporate purposes.
The Units will be offered by way of the listed issuer financing exemption under Part 5A of National Instrument 45-106 - Prospectus Exemptions ("NI 45-106") in the province of British Columbia. Pursuant to NI 45-106, the securities forming part of the Units issued to Canadian resident subscribers under the Offering will not be subject to resale restrictions.
There is an offering document related to this Offering that can be accessed under the Company's profile at www.sedarplus.com and at the Company's website www.unidoctor.com. Prospective investors should read this offering document before making an investment decision.
The Offering is expected to close on or about April 11, 2025, or such other date that is within 45 days from April 4, 2025, as the Company may agree. The Offering remains subject to certain conditions customary for transactions of this nature, including, but not limited to, the receipt of all necessary approvals, including the approval of the CSE.
On Behalf of the Board of Directors,
~Antonio Baldassarre~
Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.
About UniDoc Health Corp. (CSE:UDOC)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.comand signup to receive the latest information with updates on our activities, events and progress.
For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com
Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com
Media Inquiries media@unidoctor.com
Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Forward-looking information includes, but is not limited to: the Offering, completion of the Offering, the expected closing date of the Offering, and the use of proceeds of the Offering. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "anticipates", "anticipated" "expected" "intends" "will" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are from those expressed or implied by such forward-looking statements or forward-looking information subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different, including receipt of all necessary regulatory approvals. Although management of the Company have attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE: UniDoc Health Corp.
View the original press release on ACCESS Newswire
FAQ
What are the terms of UniDoc Health Corp's (UDOCF) LIFE offering announced in April 2025?
How much capital is UDOCF aiming to raise through its April 2025 private placement?
What will UniDoc Health (UDOCF) use the proceeds from its 2025 LIFE offering for?
When is the expected closing date for UDOCF's 2025 private placement offering?
